Table 5 Treatment-emergent adverse events (all events that occurred in >1 subject)
TEAE | TEAEs, n (%) | ||||||
|---|---|---|---|---|---|---|---|
| Â | Prednisone (mg/day) | ||||||
Placebo | 2.5 | 5 | 10 | 20 | 40 | 60 | |
(n = 15) | (n = 15) | (n = 15) | (n = 15) | (n = 16) | (n = 15) | (n = 16) | |
Total | 10 (67) | 6 (40) | 5 (33) | 2 (13) | 8 (50) | 3 (20) | 4 (25) |
Headache | 4 (27) | 4 (27) | 1 (7) | 0 | 4 (25) | 2 (13) | 3 (19) |
Nasopharyngitis | 1 (7) | 0 | 2 (13) | 1 (7) | 0 | 0 | 1 (6) |
Pharyngolaryngeal pain | 0 | 1 (7) | 1 (7) | 0 | 1 (6) | 1 (7) | 0 |
Cough | 0 | 0 | 1 (7) | 1 (7) | 1 (6) | 0 | 0 |
Dyshidrosis | 1 (7) | 0 | 0 | 0 | 1 (6) | 1 (7) | 0 |
Dyspepsia | 0 | 0 | 1 (7) | 0 | 1 (6) | 1 (7) | 0 |
Abdominal pain, upper | 0 | 1 (7) | 0 | 0 | 0 | 0 | 1 (6) |
Dermatitis, contact | 0 | 1 (7) | 1 (7) | 0 | 0 | 0 | 0 |
Dizziness | 1 (7) | 0 | 0 | 0 | 0 | 0 | 1 (6) |
Dysmenorrhea | 0 | 0 | 0 | 0 | 1 (6) | 0 | 1 (6) |
Furuncle | 1 (7) | 0 | 1 (7) | 0 | 0 | 0 | 0 |
Nausea | 0 | 0 | 0 | 0 | 0 | 1 (7) | 1 (6) |
Pyrexia | 1 (7) | 0 | 1 (7) | 0 | 0 | 0 | 0 |